Celltrion USA

Celltrion USA, Inc. is the U.S. subsidiary of Celltrion and the exclusive distributor of its COVID-19 test kit. By launching the world's first "antibody biosimilar" in countries with relatively underdeveloped pharmaceutical industries, Celltrion achieved what many thought was impossible. The company has pioneered numerous uncharted territories and achieved tremendous success. It plans to continue evolving into a global biopharmaceutical company with a unique approach to small molecule drugs and new ventures, such as its ubiquitous healthcare platform business. The company aims to become a global pharmaceutical leader by developing next-generation biopharmaceuticals and small molecule medicines to promote health and well-being for all.